about
Efflux-mediated drug resistance in bacteria: an updateAll you need is light: antimicrobial photoinactivation as an evolving and emerging discovery strategy against infectious diseaseStrategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosisStructural and functional characterization of the Mycobacterium tuberculosis uridine monophosphate kinase: insights into the allosteric regulation.Inhibition of 1-Deoxy- d -Xylulose-5-Phosphate Reductoisomerase by Lipophilic Phosphonates: SAR, QSAR, and Crystallographic StudiesSlow elimination of multidrug-resistant tuberculosisGenome analysis of multi- and extensively-drug-resistant tuberculosis from KwaZulu-Natal, South AfricaGenomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprintsMacrophages sequester clofazimine in an intracellular liquid crystal-like supramolecular organizationEvaluation of genotype MTBDRsl assay to detect drug resistance associated with fluoroquinolones, aminoglycosides and ethambutol on clinical sedimentsIncidence and risk factors for extensively drug-resistant tuberculosis in Delhi regionKinetic mechanism determination and analysis of metal requirement of dehydroquinate synthase from Mycobacterium tuberculosis H37Rv: an essential step in the function-based rational design of anti-TB drugsReduced virulence of an extensively drug-resistant outbreak strain of Mycobacterium tuberculosis in a murine modelGenome Analysis of the First Extensively Drug-Resistant (XDR) Mycobacterium tuberculosis in Malaysia Provides Insights into the Genetic Basis of Its Biology and Drug ResistanceEvolution of Extensively Drug-Resistant Tuberculosis over Four Decades: Whole Genome Sequencing and Dating Analysis of Mycobacterium tuberculosis Isolates from KwaZulu-NatalThe dUTPase enzyme is essential in Mycobacterium smegmatisRepurposing clinically approved cephalosporins for tuberculosis therapyFast standardized therapeutic-efficacy assay for drug discovery against tuberculosis.Synergistic drug combinations for tuberculosis therapy identified by a novel high-throughput screen.Genome analysis of 17 extensively drug-resistant strains reveals new potential mutations for resistance.Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa.The Mycobacterium tuberculosis FAS-II dehydratases and methyltransferases define the specificity of the mycolic acid elongation complexes.Essential metabolites of Mycobacterium tuberculosis and their mimicsTreatment outcome and mortality among patients with multidrug-resistant tuberculosis in tuberculosis hospitals of the public sectorIsoniazid inhibits the heme-based reactivity of Mycobacterium tuberculosis truncated hemoglobin NModelling the performance of isoniazid preventive therapy for reducing tuberculosis in HIV endemic settings: the effects of network structure.Development of genetically engineered iNKT cells expressing TCRs specific for the M. tuberculosis 38-kDa antigen.The Mycobacterium tuberculosis ClpP1P2 Protease Interacts Asymmetrically with Its ATPase Partners ClpX and ClpC1Management of drug-resistant spinal tuberculosis with a combination of surgery and individualised chemotherapy: a retrospective analysis of thirty-five patients.First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistancesRecombinant adenovirus delivery of calreticulin-ESAT-6 produces an antigen-specific immune response but no protection against a Mycobacterium tuberculosis challenge.Epidemiology and challenges to the elimination of global tuberculosis.Importance of the genetic diversity within the Mycobacterium tuberculosis complex for the development of novel antibiotics and diagnostic tests of drug resistanceFrom many deaths to some few cases of drug-resistant tuberculosis: travelling with the systems quality improvement model in Lacs Health District, TogoThe challenge of managing extensively drug-resistant tuberculosis at a referral hospital in the state of São Paulo, Brazil: a report of three cases.Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyondBeijing genotype of Mycobacterium tuberculosis is significantly associated with high-level fluoroquinolone resistance in Vietnam.Mycobacterium tuberculosis: drug resistance and future perspectives.Boosting BCG to protect against TB.Epidemiological models of Mycobacterium tuberculosis complex infections.
P2860
Q24609407-A45CE7E0-2C11-42C7-B7FF-A4FB69368BC7Q26830053-D5627337-56E4-4577-B70F-BAFA6199D34CQ27003186-9DACF17C-AF03-4763-81AD-D23D4583C9A3Q27666341-0021AE9E-8848-44FE-BCF5-39ABF0B4D9CBQ27667791-E08FBFB5-D028-4B6A-870C-09D183FEA98CQ28278696-A1ADE30A-6C9D-44B9-8C19-67E3196EA9A8Q28471774-C6F7D9DF-8DEB-4A3B-A834-4C5E26AB4EB9Q28476294-4F28B7C6-D254-4B5E-89C5-7E2E2D5399A6Q28484367-EECAFBED-970D-4B19-879E-1458781E073BQ28485224-9A90CC7E-854F-4783-A6E7-F1C48F4B8F45Q28485946-B2B728A0-0434-4283-9D05-07ACC29B731DQ28486831-DC05DD42-3809-45C6-9916-50F26AE213F0Q28537876-5C84A052-29EB-4767-929F-86E7968828F9Q28545741-8F2CE25C-BBFD-44C5-A3CF-9CA68DEC5CF2Q28548604-F1126D95-F4D4-4DC6-9E5D-00B5A99120B5Q28729224-EF5D2CF3-7176-4006-A411-511420D987C3Q28828720-66481D2F-3FA5-4B2B-A4D0-ED5C622CF19EQ33826465-AD555406-8FDA-4C31-9928-CF27428CD31EQ33901935-739CD4E6-EA9B-4F67-8F2D-0A9E3D3D0150Q33985151-7C3D180A-D717-40AA-87AB-C6690A79A2A0Q34101580-FFA9ED02-1890-4BBF-BB72-A496A18BCC83Q34117721-ED377D04-3026-48C1-A212-EC216F7A3B35Q34162040-741C6AA8-B3C4-4B32-81DA-CB8F2709365BQ34451895-4AFCBF8B-1FCB-4F42-BCCC-AC572EFDEFE3Q34924586-58107CE5-4F30-4B12-92AA-A22AAAA7ED17Q35185440-FABEEA98-9590-4A9E-9174-B9B9AC12B23AQ35595346-A47ED7C4-7A30-41C0-B580-CBC4CDA2457FQ35620145-6A35CB20-0E42-41A5-81E0-7C49D5A97A33Q35767108-D1D7F0C6-73F5-43B7-831F-E86158215D30Q35867811-BBA799E6-0803-4DBA-8DE7-59AFFF7011F7Q35919921-BCB80A52-349F-4028-B995-A53E2BF00825Q36073115-29F421DC-3A54-45B1-B148-246641B17953Q36396241-1052904C-90E1-45A3-B7F3-6B22B40EEE80Q36409177-D838BBE4-BEF2-446B-BCAA-8D03AD195DD2Q36490639-9175F87B-43DC-4F91-ABE6-E68105FD0FB1Q37318721-2B19102B-3F2F-4524-8D4C-32C8AD7992A3Q37409925-2E97ED19-111C-40CB-8A9D-151A1333DA3BQ37506524-F152CAE8-638B-422F-838E-AB266A474F73Q37762830-22E9BEE0-2382-4099-B2C4-D1CCC4B06BD9Q37990315-430E02E5-D4A0-4636-B0FD-5A25BB425FB7
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Extensively drug-resistant tuberculosis.
@en
Extensively drug-resistant tuberculosis.
@nl
type
label
Extensively drug-resistant tuberculosis.
@en
Extensively drug-resistant tuberculosis.
@nl
prefLabel
Extensively drug-resistant tuberculosis.
@en
Extensively drug-resistant tuberculosis.
@nl
P1476
Extensively drug-resistant tuberculosis.
@en
P2093
Mandeep Jassal
William R Bishai
P356
10.1016/S1473-3099(08)70260-3
P577
2008-11-05T00:00:00Z